Dental Service Organization (DSO) Consolidation & Multiple Arbitrage
Structure legally compliant Dental Practice Management agreements, optimize multi-specialty clinical referral funnels (orthodontics, oral surgery, periodontics), and capture 6x–14x EBITDA exit multiples.
Dental consolidation remains one of the most mature sectors in healthcare private equity, yet it faces rising regulatory scrutiny under state Dental Practice Acts. Non-dentist investors cannot own clinical dental entities or influence treatment planning in strict states. Concurrently, standalone general dentistry practices command low valuation multiples (3x–5x EBITDA) due to high chair vacancy and doctor-producer dependency. Kompanie LLP guides private equity sponsors in architecting specialized DSO networks: pairing high-volume general dentistry with high-margin clinical ancillaries (implants, aligners, oral surgery), centralizing billing and dental insurance fee negotiations, and preserving clinician equity alignment.
Deliverables
- Turnkey Friendly Dental PC corporate charter drafting compliant with state Dental Board rules.
- Dentist employment agreements featuring production-tiered compensation (30-35% collections) and rollover equity.
- Centralized dental billing and commercial insurance PPO fee schedule renegotiation playbooks.
- Cross-specialty referral capture protocols linking pediatric, orthodontic, and oral surgery clinical suites.
Frequently asked questions
How does a DSO navigate state prohibitions on the corporate practice of dentistry?
We implement a Friendly-PC model where a state-licensed dentist owns 100% of the professional entity shares under a stock transfer restriction agreement. The DSO enters into a comprehensive Business Support Agreement (BSA) providing equipment, non-clinical staff, IT, and marketing in exchange for an FMV management fee.
What is the multiple spread between solo dental practices and institutional DSOs?
Solo general dentistry practices typically transact at 3.5x to 5.5x adjusted EBITDA. When consolidated into a branded, multi-specialty regional DSO with centralized billing and over $10M in platform EBITDA, valuation multiples expand to 11x to 14x at secondary recapitalization.